Guangdong Transtek Financials
| 300562 Stock | 16.30 0.15 0.93% |
Guangdong | Select Account or Indicator |
Understanding current and past Guangdong Transtek Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Guangdong Transtek's financial statements are interrelated, with each one affecting the others. For example, an increase in Guangdong Transtek's assets may result in an increase in income on the income statement.
Please note, the presentation of Guangdong Transtek's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Guangdong Transtek's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Guangdong Transtek's management manipulating its earnings.
Guangdong Transtek Stock Summary
Guangdong Transtek competes with Jiahe Foods, Xiangpiaopiao Food, Changjiang Publishing, Time Publishing, and Shandong Publishing. Guangdong Transtek is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100002DJ6 |
| Business Address | Torch Development Zone, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.lifesense.com |
| Phone | 86 76 8516 6286 |
You should never invest in Guangdong Transtek without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Guangdong Stock, because this is throwing your money away. Analyzing the key information contained in Guangdong Transtek's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Guangdong Transtek Key Financial Ratios
Guangdong Transtek's financial ratios allow both analysts and investors to convert raw data from Guangdong Transtek's financial statements into concise, actionable information that can be used to evaluate the performance of Guangdong Transtek over time and compare it to other companies across industries.| Revenue | 884.26 M | ||||
| Gross Profit | 366.25 M | ||||
| EBITDA | 66.31 M | ||||
| Net Income | 31.2 M | ||||
| Total Asset | 1.56 B |
Guangdong Transtek Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.4B | 1.8B | 1.5B | 1.6B | 1.8B | 904.3M | |
| Other Current Liab | 817.9K | 1.6M | 1.1M | 620.7K | 558.7K | 530.7K | |
| Net Debt | (286.2M) | (398.5M) | (451.1M) | (531.5M) | (478.3M) | (454.4M) | |
| Retained Earnings | 273.5M | 237.8M | 203.5M | 234.3M | 269.5M | 165.9M | |
| Accounts Payable | 577.2M | 546.3M | 258.6M | 257.2M | 295.8M | 235.6M | |
| Cash | 327.1M | 436.0M | 595.3M | 666.5M | 766.4M | 804.8M | |
| Net Receivables | 316.7M | 426.4M | 215.1M | 226.1M | 260.0M | 183.3M | |
| Inventory | 226.0M | 208.8M | 111.2M | 86.6M | 99.6M | 95.4M | |
| Other Current Assets | 57.9M | 19.2M | 4.0M | 9.0M | 10.4M | 9.9M | |
| Total Liab | 728.0M | 747.1M | 548.5M | 532.3M | 612.2M | 351.3M | |
| Total Current Assets | 927.7M | 1.2B | 985.1M | 999.4M | 1.1B | 603.8M | |
| Intangible Assets | 64.1M | 74.9M | 78.7M | 66.4M | 76.4M | 48.8M | |
| Common Stock | 190.2M | 214.5M | 214.7M | 216.9M | 249.4M | 140.1M | |
| Net Tangible Assets | 465.0M | 504.4M | 583.7M | 963.9M | 1.1B | 570.8M | |
| Other Liab | 778.3K | 3.0M | 14.3M | 22.9M | 26.3M | 27.7M | |
| Good Will | 18.6M | 25.8M | 21.0M | 17.6M | 15.8M | 16.2M | |
| Net Invested Capital | 694.4M | 1.1B | 1.1B | 1.2B | 1.3B | 906.9M | |
| Short Long Term Debt | 40.9M | 16.6M | 133.1M | 123.8M | 142.3M | 149.5M | |
| Net Working Capital | 214.0M | 479.6M | 483.8M | 509.9M | 586.4M | 377.2M | |
| Short Term Debt | 40.9M | 24.6M | 138.8M | 128.2M | 147.4M | 154.8M | |
| Capital Stock | 190.2M | 214.5M | 214.7M | 216.9M | 249.4M | 222.7M |
Guangdong Transtek Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 376.7K | 2.6M | 2.4M | 4.3M | 4.9M | 5.2M | |
| Total Revenue | 1.3B | 1.8B | 1.1B | 884.3M | 1.0B | 882.1M | |
| Gross Profit | 334.3M | 337.7M | 252.4M | 273.6M | 314.6M | 222.1M | |
| Operating Income | 72.2M | 85.2K | (41.1M) | 34.5M | 31.1M | 25.8M | |
| Ebit | 75.7M | 14.0M | 9.0M | 37.4M | 33.7M | 32.1M | |
| Ebitda | 90.4M | 38.2M | 39.5M | 66.3M | 76.3M | 57.2M | |
| Cost Of Revenue | 1.0B | 1.5B | 812.7M | 610.7M | 702.3M | 660.1M | |
| Income Before Tax | 71.9M | (3.2M) | (44.6M) | 33.1M | 29.8M | 28.1M | |
| Net Income | 70.2M | 8.9M | (32.3M) | 34.4M | 30.9M | 25.6M | |
| Income Tax Expense | 4.0M | (2.9M) | (6.4M) | 1.9M | 1.7M | 1.6M | |
| Research Development | 96.5M | 149.2M | 136.9M | 108.3M | 124.6M | 81.6M | |
| Minority Interest | 1.5M | 9.1M | 5.8M | 3.2M | 3.6M | 3.3M | |
| Tax Provision | 4.0M | (2.9M) | (6.4M) | 1.9M | 1.7M | 3.1M | |
| Net Interest Income | 444.1K | 4.3M | 3.8M | 2.6M | 3.0M | 1.7M | |
| Interest Income | 1.6M | 7.9M | 7.1M | 7.4M | 8.5M | 9.0M |
Guangdong Transtek Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Guangdong Transtek. It measures of how well Guangdong is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Guangdong Transtek brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Guangdong had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Guangdong Transtek has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (132.0M) | 15.2M | 66.1M | 28.9M | 33.3M | 34.9M | |
| Change In Cash | 35.3M | 131.1M | 216.2M | 84.8M | 97.6M | 52.9M | |
| Free Cash Flow | (21.3M) | (68.7M) | 63.6M | 61.2M | 70.4M | 74.0M | |
| Depreciation | 14.7M | 24.2M | 30.6M | 28.9M | 33.2M | 34.9M | |
| Other Non Cash Items | 17.7M | 20.9M | 53.4M | 12.9M | 14.8M | 10.7M | |
| Dividends Paid | 4.8M | 44.7M | 3.5M | 5.6M | 6.5M | 10.1M | |
| Capital Expenditures | 99.3M | 67.8M | 21.0M | 12.9M | 14.8M | 14.1M | |
| Net Income | 67.9M | (275.1K) | (38.1M) | 31.2M | 28.1M | 24.1M | |
| End Period Cash Flow | 197.6M | 328.7M | 544.9M | 629.8M | 724.2M | 760.4M | |
| Investments | 51.3M | (119.4M) | 12.5M | 18.4M | 21.1M | 22.2M | |
| Net Borrowings | (7.9M) | 10.9M | 11.1M | (31.3M) | (28.2M) | (26.8M) | |
| Change To Netincome | 5.1M | (3.7M) | 12.3M | 8.2M | 9.4M | 9.8M |
Guangdong Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangdong Transtek's current stock value. Our valuation model uses many indicators to compare Guangdong Transtek value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangdong Transtek competition to find correlations between indicators driving Guangdong Transtek's intrinsic value. More Info.Guangdong Transtek Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangdong Transtek Medical is roughly 2.52 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Guangdong Transtek by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Guangdong Transtek's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Guangdong Transtek Systematic Risk
Guangdong Transtek's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Guangdong Transtek volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Guangdong Transtek correlated with the market. If Beta is less than 0 Guangdong Transtek generally moves in the opposite direction as compared to the market. If Guangdong Transtek Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Guangdong Transtek is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Guangdong Transtek is generally in the same direction as the market. If Beta > 1 Guangdong Transtek moves generally in the same direction as, but more than the movement of the benchmark.
Guangdong Transtek Medical Total Assets Over Time
Guangdong Transtek Thematic Clasifications
Guangdong Transtek Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Guangdong Transtek March 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Guangdong Transtek help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Guangdong Transtek Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Guangdong Transtek Medical based on widely used predictive technical indicators. In general, we focus on analyzing Guangdong Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Guangdong Transtek's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.77 | |||
| Information Ratio | 0.0748 | |||
| Maximum Drawdown | 28.07 | |||
| Value At Risk | (7.13) | |||
| Potential Upside | 6.08 |
Complementary Tools for Guangdong Stock analysis
When running Guangdong Transtek's price analysis, check to measure Guangdong Transtek's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangdong Transtek is operating at the current time. Most of Guangdong Transtek's value examination focuses on studying past and present price action to predict the probability of Guangdong Transtek's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangdong Transtek's price. Additionally, you may evaluate how the addition of Guangdong Transtek to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |